The nation of Zimbabwe has turned down a substantial US health deal worth 367 million US dollars (£272m) over five years over the United States' request for sensitive data.
The decision became public after a official document from December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "lopsided".
An official spokesman later explained that the United States was demanding access to biological samples for scientific study and commercial purposes but was not willing to share the benefits from any future treatments.
"We must now begin the difficult and regrettable process of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had furnished more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has called for further dialogue to find a deal acceptable to all parties so the nation's vital HIV programme can continue.
Wider Background
This development follows a comparable situation in neighbouring Kenya, where a court blocked a related health funding agreement following concerns were filed about the safety of citizens' medical information.
After resuming office last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
The agency had managed aid for the US government, but Trump claimed its spending was "inefficient" and his government was seeking government-to-government agreements to enhance openness and accountability.
Based on reports, Sixteen nations in Africa have to date signed similar health pacts, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Agreement
The funds for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership would have delivered extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million presently receiving antiretroviral therapy via American-funded programmes," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".
"The proposal required Zimbabwe to share its genetic material and health information over an extended period, without any corresponding guarantee of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.
"Effectively, our nation would supply the basic resources for medical research without any assurance that the end products would be accessible to our people should a new pandemic arise."
Sovereignty and International Frameworks
He also noted that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were disrupting structures previously set up via the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to manage future global health emergencies.
"This mechanism is designed to ensure that when a country contributes its data, the resulting advantages – including medicines and cures – are shared equitably, not monopolised solely by those with the funds to create them."
The government's concerns over the US deal "must not be interpreted as opposition to America," he added.
"We welcome continued discussions with our American counterparts on how subsequent collaboration might be arranged in a manner that respects the sovereignty and interests of each country."
Health Experts Reaction
Medical experts expressed it understood the government's concerns, but suggested that talks must proceed considering a large portion of the nation's HIV programmes were funded by foreign aid.
"In cases where specific concerns exist, including those involving information security or agreement terms, these can frequently be resolved through technical clarification and mutually agreed protections," it commented.
The halted deal highlights the ongoing challenges between accepting much-needed foreign assistance and safeguarding a country's data in an increasingly interconnected world.